Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Fate Therapeutics

Explore full profile

Stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics

San Diego, United StatesFounded 2007Biotech & Life Sciences
Valuation $187M Market cap · Aug/2026
Revenue $5.2M Latest reported FY

At a glance

Status
Listed
Founded
2007
Headquarters
San Diego, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom
News
News Fate Therapeutics lands $15M CIRM grant for lupus cell therapy trial Sep 28, 2026

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later7 investors entered at this stage

  • Children’s Hospital Boston
  • Harvard University
  • Scripps Translational Science Institute
  • Massachusetts General Hospital
  • Astellas Venture
  • University of Washington
  • Stanford University

Talent

Book a demo to see the people
Employees mapped 229 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 23 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 7 startups shown

Former Fate Therapeutics employees who went on to found companies, sorted by Dealroom signal score.

Scholar RockEst. 2012
Leonard ZonUnited States
Signal score93
Vivace TherapeuticsEst. 2014
Sheng DingUnited States
Signal score82
Artiva BiotherapeuticsEst. 2019
Peter FlynnUnited States
Signal score78
Syros PharmaceuticalsEst. 2012
Alex RivesUnited States
Signal score70
Clear Creek BioEst. 2017
David ScaddenUnited States
Signal score68
2 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States98.8%
🇨🇳 China0.6%
🇪🇸 Spain0.6%
3 countries shown
Web traffic by country
10K monthly visits
across markets
🇺🇸 United States64%
🏳️ Korea12%
🏳️ Republic of8%
🇮🇳 India6%
🇯🇵 Japan6%
Top 5 markets shown

Patents

Estimated portfolio value
$55M

48 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Fate Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Fate Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles